Diabetes care
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group.
To investigate the efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. ⋯ Mexiletine in a dosage of 675 mg daily can reduce pain caused by diabetic neuropathy, and the effect of this drug appears to have a rapid onset.
-
Randomized Controlled Trial Clinical Trial
Effects of an intervention by a diabetes team in hospitalized patients with diabetes.
Hospitalized patients with diabetes have a prolonged length of stay in the hospital. We conducted a controlled prospective randomized feasibility study of the effects of a diabetes team (a diabetes nurse educator and an endocrinologist) on the length of stay and other outcomes of hospitalization in these patients. ⋯ Randomized controlled prospective trials of clinical interventions in hospitalized patients with diabetes are feasible. Diabetes team intervention appears to reduce the hospital length of stay and to improve glycemic control. Team intervention significantly reduces the rate of recurrent hospitalization.